日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The novel BCL-2/BCL-XL inhibitor APG-1252-mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer.

新型 BCL-2/BCL-XL 抑制剂 APG-1252 介导的 GSDME 裂解增强了 HER2 靶向治疗在 HER2 阳性胃癌中的抗肿瘤疗效

Luo Qiu-Yun, Yang Jing, Di Tian, Xia Zeng-Fei, Zhang Lin, Pan Wen-Tao, Shi Shan, Yang Li-Qiong, Sun Jian, Qiu Miao-Zhen, Yang Da-Jun

Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma

一线PD-1抑制剂联合化疗治疗PD-L1低表达胃癌或胃食管交界处腺癌患者的临床疗效及生物标志物探索

Sun, Yu-Ting; Lu, Shi-Xun; Lai, Ming-Yu; Yang, Xia; Guan, Wen-Long; Yang, Li-Qiong; Li, Yu-Hong; Wang, Feng-Hua; Yang, Da-Jun; Qiu, Miao-Zhen

Novel prognostic model predicts overall survival in colon cancer based on RNA splicing regulation gene expression

基于RNA剪接调控基因表达的新型预后模型预测结肠癌患者的总体生存期

Luo, Qiu-Yun; Di, Tian; Chen, Zhi-Gang; Peng, Jian-Hong; Sun, Jian; Xia, Zeng-Fei; Pan, Wen-Tao; Luo, Fan; Lu, Fei-Teng; Sun, Yu-Ting; Yang, Li-Qiong; Zhang, Lin; Qiu, Miao-Zhen; Yang, Da-Jun

Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma

HER2 改变与微卫星不稳定性状态在结直肠腺癌中的关系

Qiu, Miao-Zhen; He, Cai-Yun; Yang, Xin-Hua; Yang, Li-Qiong; Lin, Jun-Zhong; Zhou, Da-Lei; Long, Ya-Kang; Guan, Wen-Long; Jin, Ying; Li, Yu-Hong; Wang, Feng-Hua; Yang, Da-Jun; Xu, Rui-Hua

Observational cohort study of clinical outcome in Epstein-Barr virus associated gastric cancer patients

一项关于EB病毒相关胃癌患者临床结局的观察性队列研究

Qiu, Miao-Zhen; He, Cai-Yun; Yang, Da-Jun; Zhou, Da-Lei; Zhao, Bai-Wei; Wang, Xiao-Jian; Yang, Li-Qiong; Lu, Shi-Xun; Wang, Feng-Hua; Xu, Rui-Hua

Role of Systemic Treatment for Advanced/Metastatic Gastric Carcinoma in the Third-Line Setting: A Bayesian Network Analysis

系统治疗在晚期/转移性胃癌三线治疗中的作用:贝叶斯网络分析

Pan, Wen-Tao; Zhou, Su-Na; Pan, Meng-Xian; Luo, Qiu-Yun; Zhang, Lin; Yang, Da-Jun; Qiu, Miaozhen

Bcl-2/Bcl-xl inhibitor APG-1252-M1 is a promising therapeutic strategy for gastric carcinoma

Bcl-2/Bcl-xl抑制剂APG-1252-M1是一种有前景的胃癌治疗策略。

Yi, Hanjie; Qiu, Miao-Zhen; Yuan, Luping; Luo, Qiuyun; Pan, Wentao; Zhou, Suna; Zhang, Lin; Yan, Xianglei; Yang, Da-Jun

More attention should be paid to adult gastric cancer patients younger than 35 years old: extremely poor prognosis was found

应更加关注35岁以下的成年胃癌患者:研究发现他们的预后极差。

Guan, Wen-Long; Yuan, Lu-Ping; Yan, Xiang-Lei; Yang, Da-Jun; Qiu, Miao-Zhen

A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma

一种新型MDM2-p53小分子抑制剂(APG-115)可增强胃腺癌的放射敏感性

Yi, Hanjie; Yan, Xianglei; Luo, Qiuyun; Yuan, Luping; Li, Baoxia; Pan, Wentao; Zhang, Lin; Chen, Haibo; Wang, Jing; Zhang, Yubin; Zhai, Yifan; Qiu, Miao-Zhen; Yang, Da-Jun

Proposal for a New TNM Stage based on the 7(th) and 8(th) American Joint Committee on Cancer pTNM Staging Classification for Gastric Cancer

基于美国癌症联合委员会第7版和第8版pTNM胃癌分期分类的胃癌新TNM分期方案

Qiu, Miao-Zhen; Wang, Zi-Xian; Zhou, Yi-Xin; Yang, Da-Jun; Wang, Feng-Hua; Xu, Rui-Hua